A physiological concentration of anandamide promotes the migration of human endometrial fibroblast and the interaction with endothelial cells invitro

• Published in: Placenta (Eastbourne) Vol. 139; pp. 99 - 111
• Main Authors: Cañumil, Vanesa A., de la Cruz Borthiry, Fernanda L., Scheffer, Frida, Herrero, Yamila, Scotti, Leopoldina, Bogetti, María Eugenia, Parborell, Fernanda, Meresman, Gabriela F., Franchi, Ana M., Beltrame, Jimena S., Ribeiro, María L.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-08-2023
• Subjects: Amidohydrolases - genetics; Amidohydrolases - metabolism; Anandamide; Culture Media, Conditioned; Endocannabinoids - pharmacology; Endometrium; Endothelial cells; Endothelial Cells - metabolism; Female; Fibroblasts - metabolism; Humans; Migration; Pregnancy; Prostaglandin-Endoperoxide Synthases; Stromal fibroblasts; Vascular remodeling; Vascular remodeling; CB2; FAAH; Stromal fibroblasts; CB1; COX-2; Migration; AEA; Endometrium; Endothelial cells; Anandamide
• ISSN: 0143-4004; 1532-3102
• DOI: 10.1016/j.placenta.2023.06.004

The mechanisms that govern fibroblast behavior during the vascular adaptations of the uterus at early pregnancy remain unknown. Anandamide, an endocannabinoid, binds to cannabinoid receptors (CBs), and regulates gestation and angiogenesis. Its tone is regulated by fatty acid amide hydrolase (FAAH) within the uterus. We investigated the role of anandamide in endometrial fibroblasts migration and whether anandamide modulates fibroblasts-endothelial crosstalk.
T-hESC and EA.hy926 cell lines were used as models of endometrial stromal and endothelial cells, respectively. T-hESC were incubated with anandamide plus different agents. Migration was tested (wound healing assay and phalloidin staining). Protein expression and localization were studied by Western blot and immunofluorescence. To test fibroblast-endothelial crosstalk, EA.hy926 cells were incubated with fibroblast conditioned media obtained after T-hESC migration.
Anandamide 1 nM increased T-hESC migration via CB1 and CB2. Cyclooxygenase-2 participated in anandamide-stimulated fibroblast migration. Prostaglandin F2alpha, and not prostaglandin E2, increased fibroblast wound closure. CB1, CB2, cyclooxygenase-2 and FAAH were expressed in T-hESC. Anandamide did not alter cyclooxygenase-2 localization but induced its cytoplasmic and nuclear expression through CB1 and CB2. URB-597, a FAAH selective inhibitor, also increased T-hESC migration via both CBs, and augmented cyclooxygenase-2 expression. Conditioned media from anandamide-induced T-hESC wound healing closure stimulated endothelial migration and did not alter their proliferation. Soluble factors from cyclooxygenase-2 were secreted by T-hESC and participated in T-hESC-induced EA.hy926 migration. Although anandamide-conditioned media augmented in EA.hy926 the expression of γH2AX, a marker of DNA damage, cyclooxygenase-2 was not involved in this effect.
Our results provide novel evidence about an active role of anandamide on endometrial fibroblast behavior as a mechanism regulating uterine vascular adaptations in early gestation.
[Display omitted]
•Endometrial fibroblasts' role in early gestation vascular adaptations remains unknown.•A physiological level of anandamide induces the migration of endometrial fibroblasts.•Anandamide promotes endometrial fibroblast - endothelial cell interaction.•Cannabinoid receptors and cyclooxygenase-2 participate in anandamide-driven actions.•Anandamide might promote endometrial fibroblast participation in vascular remodeling.